IRIS Accounts Production v23.3.1.45 00739096 director 1.11.22 31.10.23 31.10.23 false true false false true false Fair value model Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh007390962022-10-31007390962023-10-31007390962022-11-012023-10-31007390962021-10-31007390962021-11-012022-10-31007390962022-10-3100739096ns10:Originalns15:EnglandWales2022-11-012023-10-3100739096ns14:PoundSterlingns10:Original2022-11-012023-10-3100739096ns10:Originalns10:Director12022-11-012023-10-3100739096ns10:Original2022-11-012023-10-3100739096ns10:Original2023-10-3100739096ns10:Originalns10:PrivateLimitedCompanyLtd2022-11-012023-10-3100739096ns10:Originalns10:SmallEntities2022-11-012023-10-3100739096ns10:Originalns10:AuditExempt-NoAccountantsReport2022-11-012023-10-3100739096ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-11-012023-10-3100739096ns10:SmallCompaniesRegimeForAccountsns10:Original2022-11-012023-10-3100739096ns10:Originalns10:FullAccounts2022-11-012023-10-3100739096ns10:Originalns10:OrdinaryShareClass12022-11-012023-10-3100739096ns10:Originalns10:RegisteredOffice2022-11-012023-10-3100739096ns10:Original2022-10-3100739096ns10:Originalns5:CurrentFinancialInstruments2023-10-3100739096ns10:Originalns5:CurrentFinancialInstruments2022-10-3100739096ns5:ShareCapitalns10:Original2023-10-3100739096ns5:ShareCapitalns10:Original2022-10-3100739096ns10:Originalns5:FurtherSpecificReserve3ComponentTotalEquity2023-10-3100739096ns10:Originalns5:FurtherSpecificReserve3ComponentTotalEquity2022-10-3100739096ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-10-3100739096ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-10-3100739096ns10:Original2021-11-012022-10-3100739096ns10:Original2022-10-3100739096ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-10-3100739096ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-10-3100739096ns10:Originalns10:OrdinaryShareClass12023-10-3100739096ns10:Originalns5:FurtherSpecificReserve3ComponentTotalEquity2022-10-31
REGISTERED NUMBER: 00739096 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 October 2023

for

Staplehurst Chemists Limited

Staplehurst Chemists Limited (Registered number: 00739096)






Contents of the Financial Statements
for the Year Ended 31 October 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Staplehurst Chemists Limited

Company Information
for the Year Ended 31 October 2023







DIRECTOR: Mrs E M Wellington





REGISTERED OFFICE: Bank Chambers
61 High Street
Cranbrook
Kent
TN17 3EG





REGISTERED NUMBER: 00739096 (England and Wales)





ACCOUNTANTS: McCabe Ford Williams
Bank Chambers
61 High Street
Cranbrook
Kent
TN17 3EG

Staplehurst Chemists Limited (Registered number: 00739096)

Balance Sheet
31 October 2023

31.10.23 31.10.22
Notes £    £    £    £   
FIXED ASSETS
Investment property 4 275,000 275,000

CURRENT ASSETS
Debtors 5 - 2,244
Cash at bank 30,742 11,447
30,742 13,691
CREDITORS
Amounts falling due within one year 6 14,675 7,263
NET CURRENT ASSETS 16,067 6,428
TOTAL ASSETS LESS CURRENT
LIABILITIES

291,067

281,428

PROVISIONS FOR LIABILITIES 51,336 51,336
NET ASSETS 239,731 230,092

CAPITAL AND RESERVES
Called up share capital 7 100 100
Fair value reserve 8 218,854 218,854
Retained earnings 20,777 11,138
SHAREHOLDERS' FUNDS 239,731 230,092

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Staplehurst Chemists Limited (Registered number: 00739096)

Balance Sheet - continued
31 October 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 14 February 2024 and were signed by:





Mrs E M Wellington - Director


Staplehurst Chemists Limited (Registered number: 00739096)

Notes to the Financial Statements
for the Year Ended 31 October 2023

1. STATUTORY INFORMATION

Staplehurst Chemists Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover represents rent receivable.


Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 2 ) .

Staplehurst Chemists Limited (Registered number: 00739096)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023

4. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 November 2022
and 31 October 2023 275,000
NET BOOK VALUE
At 31 October 2023 275,000
At 31 October 2022 275,000

Fair value at 31 October 2023 is represented by:
£   
Valuation in 2019 275,000

If the investment property had not been revalued it would have been included at the following historical cost:

31.10.23 31.10.22
£    £   
Cost 4,810 4,810

The investment property was valued on an open market basis on 5 September 2019 by Bracketts Chartered Surveyors .

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.23 31.10.22
£    £   
Other debtors - 2,244

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.23 31.10.22
£    £   
Taxation and social security 276 1,542
Other creditors 14,399 5,721
14,675 7,263

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.10.23 31.10.22
value: £    £   
100 Ordinary £1 100 100

Staplehurst Chemists Limited (Registered number: 00739096)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023

8. RESERVES
Fair
value
reserve
£   
At 1 November 2022
and 31 October 2023 218,854